HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Nakaraang pagsara
$2.22
Sakop ng araw
$2.22 - $2.37
Sakop ng taon
$1.78 - $17.49
Market cap
97.67M USD
Average na Volume
278.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 10.36M | 145.80% |
Net na kita | -37.49M | -81.40% |
Net profit margin | — | — |
Kita sa bawat share | -0.88 | 98.84% |
EBITDA | -43.52M | -105.78% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 285.98M | 396.98% |
Kabuuang asset | 304.64M | 305.14% |
Kabuuang sagutin | 38.06M | 46.28% |
Kabuuang equity | 266.59M | — |
Natitirang share | 43.21M | — |
Presyo para makapag-book | 0.36 | — |
Return on assets | -34.05% | — |
Return on capital | -37.36% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -37.49M | -81.40% |
Cash mula sa mga operasyon | -37.06M | -99.65% |
Cash mula sa pag-invest | 29.22M | -7.76% |
Cash mula sa financing | -215.00K | 85.01% |
Net change in cash | -8.05M | -168.93% |
Malayang cash flow | -24.08M | -127.10% |
Tungkol
Itinatag
2018
Headquarters
Website
Mga Empleyado
112
